Medicine Description sifrol-uae 0.7 mg
sifrol 0.7 mg 30 tablets - rosheta uae is a medication that contains the active ingredient pramipexole, which functions as a selective agonist at dopamine D2 and D3 receptors in the brain. By mimicking the action of dopamine, a crucial neurotransmitter in the regulation of movement and mood, pramipexole helps restore balance in the dopaminergic system, thereby alleviating motor symptoms associated with Parkinson's disease and improving the quality of life for affected individuals. This action not only addresses movement-related symptoms but also enhances overall motor control and coordination, making it effective in managing both Parkinson's disease and Restless Legs Syndrome.
Indications and Uses of sifrol 0.7 mg 30 tablets - rosheta uae
- Treatment of Parkinson's Disease
- Management of Restless Legs Syndrome
Side Effects of sifrol 0.7 mg 30 tablets - rosheta uae
- Nausea
- Dizziness
- Somnolence
- Constipation
- Insomnia
- Orthostatic hypotension
- Hallucinations
Storage and Handling
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.
Patient Advice and Precautions
Before starting treatment, inform your healthcare provider about any existing medical conditions or medications you are taking. Regular follow-up appointments are essential to monitor your response to treatment and adjust doses as needed. Avoid abrupt discontinuation of the medication to prevent withdrawal symptoms. Be cautious when driving or operating machinery until you understand how this medication affects you.